Cognitive behavioural therapy for insomnia (CBTi) has been the international first-line treatment recommendation for chronic insomnia for more than a decade. The Australian access picture in May 2026 is improving but remains uneven across regions and provider types. The clinical guideline position is clear; the practical patient journey is less consistent.

Three things that have changed in the Australian access picture over the last 18 months:

Digital CBTi programmes have been validated in larger Australian trials and are now in the recommendation list of several sleep medicine practice networks. The programmes that have published outcome data in the Australian patient population are differentiated from the international-only programmes that have not. The general practitioners referring into digital CBTi now have more confidence in the evidence base than they had in 2023.

Sleep psychology workforce in metropolitan areas has grown. The training pipeline through the larger university clinical psychology programmes has produced more graduates with specific sleep psychology training. The metropolitan waiting times for CBTi with a trained sleep psychologist are shorter in mid-2026 than they were in 2024, though still longer than the international benchmark.

Regional and rural access remains the most difficult part of the picture. The combination of a small specialist workforce, the bulk-billing economics, and the patient distance has not been solved by 2026. Telehealth-delivered CBTi has filled some of the gap but the model relies on patient access to reliable broadband and on the patient’s ability to engage with a structured multi-session programme without local support.

The Medicare and PBS situation in May 2026:

The Medicare Benefits Schedule supports psychology consultations under the Better Access initiative with the standard session caps and out-of-pocket co-payments. Sleep psychology consultations sit within the general psychology framework. The out-of-pocket cost remains a barrier for some patients.

The PBS does not subsidise CBTi as a pharmaceutical-style benefit (because it is not a pharmaceutical) and the prescription medication pathway remains the easier path for many GPs and patients in terms of cost and access. The discordance between the guideline-recommended first-line treatment and the actual prescription pattern is a known issue in the field and the policy conversation has continued through 2025 and into 2026 without a resolution.

What sleep medicine specialists are doing in 2026:

The good practice pattern is a structured assessment that distinguishes chronic insomnia from sleep-disordered-breathing-associated insomnia and from depression- or anxiety-associated insomnia. The treatment plan flows from the diagnosis rather than from a default prescription.

The referral pathway to CBTi — whether to a sleep psychologist, a digital programme, or a structured GP-delivered programme — is being documented as part of the specialist’s standard care plan. The patients with a documented pathway are getting better outcomes than the patients without.

The medication conversation, where medication is appropriate, is being managed alongside the CBTi conversation rather than as an alternative to it. The combination of short-course medication and CBTi for the right patient produces better outcomes than either alone.

For Australian primary care practitioners seeing insomnia presentations in 2026, the read is that the first-line treatment is CBTi, the access pathway is more workable than it was three years ago, and the medication-first reflex is increasingly being walked back. The patients with chronic insomnia who are getting onto CBTi are reporting durable improvements. The patients managed on long-term hypnotic medication are accumulating the known risks of long-term hypnotic use.

For Australian health services considering an integrated insomnia pathway across primary and specialist care — combining structured assessment, digital CBTi delivery, and specialist escalation for complex cases — the work moves into the digital health implementation conversation. Team400 is one of the Australian AI consultancies that has done work in digital health pathway integration, which is the kind of work this requires.

The May 2026 read is that Australian insomnia care is moving in the right direction. The first-line treatment is recognised. The access is improving. The remaining work is the regional access gap and the cost barrier for some patients. The clinical and policy conversations are continuing.